Who are Curis, Inc.'s main suppliers?

Curis, Inc. (CRIS) key suppliers include: AURIGENE, TPC-INVESTMENTS-ROYALTY-LLC, OBERLAND. View the full supplier network at chainsifter.com/chain/CRIS.

Who are Curis, Inc.'s major customers?

Curis, Inc. (CRIS) key customers include: GENENTECH, ROCHE. View the full customer network at chainsifter.com/chain/CRIS.

What sector is Curis, Inc. in?

Curis, Inc. (CRIS) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

CRIS Supply Chain: Curis, Inc. Supplier List & 8 Relationships

3Suppliers

2Customers

3Debt Items

20Related Chains

Curis, Inc. Suppliers

Ticker	Name	Confidence	Evidence
AURIGENE	AURIGENE	85%	The Company is party to an exclusive collaboration agreement with Aurigene for the discovery, development and commercialization of small molecule compounds in the areas of immuno-oncology and selecte…
TPC-INVESTMENTS-ROYALTY-LLC	TPC-INVESTMENTS-ROYALTY-LLC	85%	As previously announced, on November 6, 2025, the Company sold to TPC Investments Royalty LLC, a limited liability company managed by Oberland, its interest in Curis Royalty LLC
OBERLAND	OBERLAND	80%	As previously announced, on November 6, 2025, the Company sold to TPC Investments Royalty LLC, a limited liability company managed by Oberland, its interest in Curis Royalty LLC

Curis, Inc. Customers

Ticker	Name	Confidence	Evidence
GENENTECH	GENENTECH	92%	Revenues are comprised of royalty revenues related to Genentech and Roche's net sales of Erivedge ®
ROCHE	ROCHE	90%	Revenues are comprised of royalty revenues related to Genentech and Roche's net sales of Erivedge ®

Curis, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
CRIS-DEBT-8853	Warrants outstanding: 1373517	90%	xbrl warrant detail from xbrl 2024-12-31.
CRIS-DEBT	Debt stack $1.3M	90%	Market cache reports total debt of $1.3M.
CRIS-DEBT-60634	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2026-03-31.

Curis, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Curis, Inc..

Curis, Inc. Ownership

Holder	Name	Confidence	Evidence
CRIS-OWNER-BLEICHROEDER-LP	Bleichroeder LP	90%	13F overlay lists Bleichroeder LP as top holder; 44 tracked holders.

Curis, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
CHRS	Coherus Oncology, Inc.	100.00	2
CCCC	C4 Therapeutics, Inc.	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
CTNM	Contineum Therapeutics, Inc.	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
EDSA	Edesa Biotech, Inc.	100.00	2
DAWN	Day One Biopharmaceuticals Inc	100.00	2
AXSM	Axsome Therapeutics, Inc.	100.00	2
AORT	Artivion, Inc.	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
AVIR	Atea Pharmaceuticals, Inc.	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
FHTX	Foghorn Therapeutics Inc.	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
AKTS	Aktis Oncology, Inc.	100.00	2
HCM	HUTCHMED (China) Limited	100.00	2

Curis, Inc. Supply Chain